Rose Geoffrey Beran's Form 4 filing
Pulmonx Corp (LUNG) · filed Dec 3, 2025
- Accession no.
- 0001804146-25-000004
- Filed
- Dec 3, 2025
- Trade date
- Dec 1, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $9.93K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rose Geoffrey BeranCIK 0001804146 | Officer (CHIEF COMMERCIAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | Common Stock | SSaleDisposed | −683 | $1.57 | −$1,072.31 | 379,105 | Direct | |
| Dec 1, 2025 | Common Stock | SSaleDisposed | −1,738 | $1.57 | −$2,728.66 | 377,367 | Direct | |
| Dec 1, 2025 | Common Stock | SSaleDisposed | −1,522 | $1.57 | −$2,389.54 | 375,845 | Direct | |
| Dec 1, 2025 | Common Stock | SSaleDisposed | −2,379 | $1.57 | −$3,735.03 | 373,466 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.